Also, AZD8055 dose-dependently inhibited activation of the mTOR downstream targets, i.e., p-4EBP1 and p-S6, in both SCLC and NHBE cells indicating a desired on-target effect (Fig. 3c, d). The gene discussed is EIF4EBP1; the disease is small cell lung carcinoma.